Berry S, Roblin G, Williams A, Watkins A, Whittet H B
Department of Otorhinolaryngology-Head and Neck Surgery, Singleton Hospital, Swansea, UK.
Laryngoscope. 2005 Mar;115(3):538-40. doi: 10.1097/01.mlg.0000157849.16649.6e.
To validate the technique of sleep nasendoscopy using target controlled infusion in symptomatic patients and a control group of asymptomatic individuals.
Prospective cohort study.
Department of otolaryngology-head and neck surgery and anesthesia in a teaching hospital.
Two groups of patients were compared and matched for their body mass index. The first group consisted of 53 patients with a history suggestive of obstructive sleep apnea. The second group consisted of 54 patients with partner-confirmed history of no snoring. These patients were undergoing anesthesia for other reasons. Both groups of patients were free of associated otorhinolaryngologic symptoms.
Assessment of production of snoring or obstruction in patients with no documented history of snoring when sedation was administered as part of general anesthesia using target controlled infusion with propofol.
None of the patients in the asymptomatic group snored or obstructed at any level of propofol, and this was clearly significant on comparison with the symptomatic group (P < .001). All of the symptomatic patients were induced to become symptomatic (snoring/obstruction).
在有症状患者及无症状个体组成的对照组中,验证使用靶控输注进行睡眠鼻内镜检查的技术。
前瞻性队列研究。
一家教学医院的耳鼻咽喉头颈外科及麻醉科。
两组患者根据体重指数进行比较和匹配。第一组由53例有阻塞性睡眠呼吸暂停病史提示的患者组成。第二组由54例经伴侣确认无打鼾病史的患者组成。这些患者因其他原因接受麻醉。两组患者均无相关耳鼻咽喉症状。
在使用丙泊酚靶控输注作为全身麻醉一部分给予镇静时,对无打鼾记录病史的患者打鼾或阻塞情况进行评估。
无症状组患者在任何丙泊酚水平下均未打鼾或出现阻塞,与有症状组相比差异有统计学意义(P < .001)。所有有症状患者均诱发出症状(打鼾/阻塞)。